Cardio-Oncology: Taking Survival To Heart

What is Cardio-Oncology?

While cancer therapies continue to provide improved survival and cancer outcomes, many cancer treatments can also potentially cause adverse effects on the heart during or after treatment.  In fact, cancer survivors are at 2-6 times the risk to die from cardiovascular disease compared to those with no history of cancer. Cardio-oncologists at Washington University are heart specialists that excel in the prevention, detection and management of potential cardiac toxicities that can occur during or after cancer treatment.  The cardio-oncology team works closely with the hematology, oncology, and radiation oncology teams of the Siteman Cancer Center to help prevent or minimize cardiac side effects, maximize the cancer treatment, and give patients the best outcomes.

Cardio-Oncology Center of Excellence

The Cardio-Oncology Center of Excellence at Washington University is the embodiment of the multidiscliplinary collaboration between Hematology, Oncology, Radiation Oncology and Cardio-Oncology that provides internationally recognized care for our cancer patients.  In 2021, the center was one of only 15 centers in the world to receive the Gold Center of Excellence (the highest ranking) by the International Cardio-Oncology Society. Washington University was recognized for its outstanding patient care, innovative research, and internationally recognized leadership in the field.

Cardio-Oncology Center of Excellence

Cardio-Oncology Providers and Staff

A Cardio-Oncologist is a health care provider who is focused on the prevention, early detection, management, and recovery of cardiovascular function in patients receiving or having previously received cancer therapies.

Goals of the Cardio-Oncology Program:

  • Partner with oncologists to provide rapid consultations utilizing our special expertise in the area of cancer-derived cardiotoxicity and work closely with them in situations where a combined approach is essential.
  • Assist in screening for cardiac injury risk prior to initiating chemotherapy so that cardiac injury can be prevented or identified at the earliest opportunity to limit long-term harm.
  • Minimize delays in arranging consultations and office visits. Cancer therapy cannot wait, and the goal of the program is to see new outpatients within one week or less.
  • Coordination of care with the advanced heart failure program, as needed, for cardiac resynchronization therapy, circulatory assist devices, and cardiac transplantation.
  • Dissemination of knowledge through educational programs in cardio-oncology to oncologists, cardiologists and physicians in training
  • Creation of new knowledge through participation in multicenter clinical trials that are evaluating protocols for the detection, prevention, and treatment of cardiac toxicity in the setting of chemotherapy
  • Improved surveillance of cardiac structure and function through the use of advanced cardiac imaging, including:
    • Advanced echocardiographic imaging techniques through 3D quantification and myocardial strain-rate imaging
    • Non-invasive evaluation of coronary artery disease through computer tomographic angiography (CTA)
    • Use of Magnetic Resonance Imaging to evaluate myocardial fibrosis, inflammation, edema, and cardiac function

Patient information

Make an appointment

Referring Physicians: 314-362-1291

Patients (please identify yourself as a cancer patient and specify if an urgent clinic visit is needed): 314-362-1291 or 888-210-8375


Washington University and Barnes-Jewish Heart & Vascular Center
Center for Advanced Medicine
Washington University Medical Center
4921 Parkview Place Suite 8A
St. Louis, MO 63110
Phone: 314-362-1291

Heart & Vascular Center in South County
5201 Midamerica Plaza, Suite 2300
St. Louis, MO 63129

Heart & Vascular Center in West County
1020 North Mason, Suite 100
St. Louis, MO 63141
Phone: 314-362-1291